about
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgeryThe use of warfarin in veterans with atrial fibrillationFrequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillationStroke prevention in diabetes and obesityComparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levelsAlcohol consumption and abnormalities of brain structure and vasculature.No difference in stroke knowledge between Korean adherents to traditional and western medicine - the AGE study: an epidemiological study.Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in NigeriansPrevention of strokes.Chronic medical conditions and risk of sepsis.Evaluating the translational potential of progesterone treatment following transient cerebral ischaemia in male mice.Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy.Stroke: a review with an African perspective.Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcome.Potential nontraditional applications of statins.Epidemiology of transient ischemic attack and ischemic stroke in patients with underlying cardiovascular disease.Pathophysiology and therapeutic targets for ischemic stroke.Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.Antithrombotic trials in acute ischaemic stroke: a selective review.Statins and the prevention of stroke in diabetes.What proportion of stroke is not explained by classic risk factors?The role of statins in preventing stroke.Stroke in patients with diabetes and hypertension.Stroke prevention in diabetic and other high cardiovascular risk patients.Physical activity and stroke risk.Possible pathophysiologic mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotensin-converting enzyme inhibitors: clinical and experimental evidence.Lipids and stroke: the opportunity of lipid-lowering treatment.Sex differences in long-term outcomes among acute ischemic stroke patients with diabetes in ChinaIntracardiac devices for stroke prevention.A Meta-Analysis of the Association between Polymorphisms in MicroRNAs and Risk of Ischemic Stroke.The pleiotropic effects of angiotensin receptor blockers.Current management of extracranial carotid artery disease.Stroke risk among Chinese immigrants in New York City.Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review.Histopathology of carotid atherosclerotic disease.High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.Current strategies for ischemic stroke prevention: role of multimodal combination therapies.What should we do with asymptomatic carotid stenosis?The burden of stroke in Nigeria.Cost-effectiveness of amiodarone in cardiac surgery.
P2860
Q24245983-5617594C-B4B8-46BF-8E0E-D0B4212BC72BQ24793600-42AF8849-9A0E-4328-8337-2A710D1CEF4BQ28183704-3313D7D2-C434-48C0-9F08-D1A44EFB03BEQ28200179-EC821CAB-157A-4551-80ED-2A9CD984FAB6Q28212874-EBDCD5F1-4B80-4C1F-BBA1-0117A62D0A3BQ30887466-896E8B58-6B06-492E-9332-11D67E71EF70Q33246697-CDF2485C-4C2C-41F6-8D05-561E4F736817Q33351094-D9606911-07C8-4409-A57D-B9312A865AC3Q34271974-0CB5B8BF-7265-4AD0-8026-CAFD1A280B69Q34464936-875543AA-FF25-4BBD-A701-599096C2158CQ34632364-01A42192-7673-4170-851C-0E206FAE0715Q34691744-A541810B-EC90-403B-875B-AEDFEF914C2EQ34795617-A951B71E-B103-40ED-80DE-4EA0403473CEQ34982750-C2A90066-66CA-4B91-86BF-BBE107A801C6Q35169445-656716F7-67A3-4AEF-B71E-C45E301C5C0BQ35799740-52EE7169-E815-4248-9071-48ED2C91459EQ35799745-741F932C-F135-4A3C-AA6F-3FC5AC824608Q35925696-5FACCDC7-6D7C-4EEE-AF76-A55C9417B93CQ35967397-739B795F-9D85-43E5-93B5-CFF2FFF608D1Q36016940-50DABF5A-CB4F-49F3-B5A9-9D899BEC205BQ36050079-D93CB4E0-69B4-4F9B-80D3-CBADB0FC4CEBQ36110439-BED4AC0B-2C60-4BA9-8D22-219257D0DE99Q36123467-23A539DA-8DA0-4670-9243-3DC3E521CC3FQ36147428-9C6B20DF-49A7-4471-937F-77644DAF1085Q36201749-AA4581DA-7970-4D08-A567-E66053F4D62CQ36210252-DA4797AB-9B26-4531-879E-B280B61EAAF6Q36331015-669DE148-132F-42D3-B757-A96DB97BEA20Q36348636-9406423B-44D6-4FC1-8E78-32CEF58A77A4Q36366301-0D9FCBBF-B641-4B14-96D4-27A0BA1FE890Q36401171-612FC2FC-7FAA-482E-80D0-435EC3BD6789Q36440956-A2DE89EF-0C57-4318-9E2D-F56F98FF245EQ36480069-40A796BA-1A94-4BCD-AAFA-F71D53649B03Q36491660-96E928C8-8670-4E20-801A-0AECE41341D7Q36612606-749E5CC3-8F8E-41CD-9614-B3AF40CF3109Q36629746-7119369A-BE42-4DD2-9F2A-0D3707666DA8Q36902749-F899412B-7D1C-47C2-8EBC-BE5402373216Q36970318-93A6DCE4-0441-48C1-B6A8-90B361EE9904Q37244522-513EBCAF-BC36-4C3D-ABF3-B9C1D336D701Q37277248-EBADA9B7-AC57-4404-881B-20F120E76025Q37763148-E948002C-56E5-4B56-AEFD-9069EE969D79
P2860
description
article
@en
im Januar 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2001
@uk
name
Primary Prevention of Ischemic Stroke
@en
Primary Prevention of Ischemic Stroke
@nl
type
label
Primary Prevention of Ischemic Stroke
@en
Primary Prevention of Ischemic Stroke
@nl
prefLabel
Primary Prevention of Ischemic Stroke
@en
Primary Prevention of Ischemic Stroke
@nl
P2093
P356
P1433
P1476
Primary prevention of ischemic ...... the American Heart Association
@en
P2093
Furberg CD
Goldstein LB
Gorelick PB
Hademenos G
P304
P356
10.1161/01.CIR.103.1.163
P407
P577
2001-01-01T00:00:00Z